HTB homepage • Conference reports • Articles by subject • Subscribe April 2011 Contents Editorial Volume 12 Number 3/4 March/April 2011 Conference reports 18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston New antiretrovirals: dolutegravir, entry inhibitor (BMS-663068) and tenofovir pro-drug (GS-7340) Immune-based treatment increases HIV-resistant CD4 cells in phase 1 study Antiretroviral prevention: oral PrEP, gels and treatment studies Further efficacy analyses from the iPrEx study Topical gels as PEP and PrEP: animal and human studies Maternal risk following short course HAART Pre-term delivery and HAART HAART more effective than AZT monotherapy in the Botswana PMTCT programme Lopinavir/r monotherapy for PMTCT No evidence of increased risk of MTCT with sequential pregnancies in UK and Ireland Recently infected women at the time of delivery have a higher rate of in-utero transmission in PEPI-Malawi Reduced CCL22 concentrations in cervicovaginal secretions from pregnant women First results from telaprevir in HIV/HCV coinfection HCV reinfection rates in HIV-positive gay men Antiretrovirals London HIV Consortium issues new guidelines for ARV prescribing (2011) EMA issue restricted indication for d4T (stavudine) Changes to starting dose of saquinavir in naive patients FDA approve nevirapine XR Lopinavir/r oral solution Atazanavir use during pregnancy Nelfinavir interaction with warfarin Treatment access FDA approval of generic ARVs Global Fund reports rise in people on treatment UK increases funding to the Global Fund UK government development priorities and HIV Update on the Patent Pool TRIPS agreement flexibilities provide opportunities for improved access to ARVs Driving a decade of change: HIV/AIDS, patents and access to medicines for all Pregnancy Lower incidence of pregnancy in HIV positive compared to HIV negative women in the Womens Interagency HIV Study Paediatric care Long-term outcomes for infants starting lopinavir/ritonavir at less than 6 months Effects of antiretroviral exposure through PMTCT strategies on infants in Botswana PK and drug interactions No interaction between raltegravir and oral contraceptives Case report: extreme bradycardia with lopinavir/ritonavir and metoprolol and lacidipine Cure-related research Global scientific strategy towards an HIV cure Basic science and immunology Continuing debate over the role of microbial translocation in HIV infection Jostling latent HIV from slumber Dubious analysis of a therapeutic tat vaccine trial Studies on the loss of naive T cells Intensifying treatment does not reduce HIV reservoirs, but gut immune responses may have a role to play BHIVA news CROI feedback workshops online BASHH/BHIVA PEPSE guidelines for comment (2011) UK national guideline on safer sex advice Other news Online European clinical trials registry On the web Guidelines Community resources and publications Free journal articles Medical online resources PDFs Volume 12 Number 3/4 March/April 2011 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
